Publications by authors named "Aerang Kim"

Claim this Profile
A
A Pediatric Case of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor of the Scalp.
Athena Zhang, Brandon Boyarsky, Theodore S Hyman, Arhana Chattopadhyay, AeRang Kim

Plast Reconstr Surg Glob Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop, AeRang Kim

Pediatr Blood Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis, AeRang Kim

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, Paul A Jones, Sana Z Mahmood, AeRang Kim

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Marie V Nelson, AeRang Kim, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Britt A E Dhaenens, Günter Heimann, Annette Bakker, Marco Nievo, Rosalie E Ferner, AeRang Kim

Neurooncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
Liny John, Gurbani Singh, Eva Dombi, Pamela L Wolters, Staci Martin, AeRang Kim

Clin Trials· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
R Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, Paul A Jones, Sana Z Mahmood, AeRang Kim

medRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
R Taylor Sundby, Steven D Rhodes, Edina Komlodi-Pasztor, Herb Sarnoff, Vito Grasso, AeRang Kim

Clin Trials· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Andrea M Gross, Eva Dombi, Pamela L Wolters, Andrea Baldwin, Anne Dufek, AeRang Kim

Neuro Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Srivandana Akshintala, Nicole C Mallory, Yao Lu, Karla V Ballman, Scott M Schuetze, AeRang Kim

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Targeted Next-Generation Panel Sequencing Reveals Amplification Is a Poor Prognostic Factor in Osteosarcoma.
Amanda E Marinoff, Liam F Spurr, Christina Fong, Yvonne Y Li, Suzanne J Forrest, AeRang Kim

JCO Precis Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, Eva Dombi, Andrea Baldwin, AeRang Kim

Neuro Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag, AeRang Kim

Neuro Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.
Lorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, Alyaa Al-Ibraheemi, Hersh Gupta, AeRang Kim

JCO Precis Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents.
Teresa González-Muñoz, AeRang Kim, Nancy Ratner, Héctor Peinado

Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Alanna J Church, Laura B Corson, Pei-Chi Kao, Alma Imamovic-Tuco, Deirdre Reidy, AeRang Kim

Nat Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor.
Jaclyn Schienda, Alanna J Church, Laura B Corson, Brennan Decker, Catherine M Clinton, AeRang Kim

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Ultrasound for Pediatric Diseases.
Rohan Janwadkar, Suzanne Leblang, Pejman Ghanouni, Jacqueline Brenner, John Ragheb, AeRang Kim

Pediatrics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
Holly J Meany, Brigitte C Widemann, Pamela S Hinds, Rochelle Bagatell, Suzanne Shusterman, Aerang Kim

Pediatr Blood Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging hyperthermia applications for pediatric oncology.
Caitlin Tydings, Karun V Sharma, AeRang Kim, Pavel S Yarmolenko

Adv Drug Deliv Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
Chetan Bettegowda, Meena Upadhayaya, D Gareth Evans, AeRang Kim, Dimitrios Mathios

Neurology· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.
Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, Eva Dombi, John Myseros, AeRang Kim

Neurooncol Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac changes in pediatric cancer survivors.
Deepa Mokshagundam, Laura J Olivieri, Robert McCarter, Aerang Kim, Craig A Sable

J Investig Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Current Technical Exclusion Criteria for Clinical Trials of Magnetic Resonance-Guided High-Intensity Focused Ultrasound Too Restrictive?: Early Experiences at a Pediatric Hospital.
Lung W Lau, Avinash Eranki, Haydar Celik, AeRang Kim, Peter C W Kim

J Ultrasound Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis